Inventor · disambiguated record
Jörg Rosenberg
Also filed as: ROSENBERG JOERG · ROSENBERG JORG · Rosenberg Jörg
19 granted patents·18 pending applications·408 citations·filing 1998–2021
95Inventor score
Top patents by PatentIndex Score
37 records- 0193US6599528B1Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substancesABBOTT GMBH & CO KG·Filed 2000·Granted Jul 29, 2003·50 cites·6 claims
- 0291US6547997B1Method for producing solvent-free noncrystalline biologically active substancesABBOTT LAB·Filed 1998·Granted Apr 15, 2003·117 cites·12 claims
- 0387US9205027B2Process for producing a solid dispersion of an active ingredientABBVIE DEUTSCHLAND·Filed 2013·Granted Dec 8, 2015·9 cites·27 claims
- 0484US7014810B2Method of producing solid shape forms containing an active ingredientABBOTT GMBH & CO KG·Filed 2000·Granted Mar 21, 2006·25 cites·4 claims
- 0579US9414992B2Process for producing a solid dispersion of an active ingredientABBOTT GMBH & CO KG·Filed 2013·Granted Aug 16, 2016·3 cites·28 claims
- 0676US6322816B1Fast-acting analgesicBASF AG·Filed 1998·Granted Nov 27, 2001·46 cites·10 claims
- 0773US8470347B2Self-emulsifying active substance formulation and use of this formulationBERNDL GUNTHER·Filed 2001·Granted Jun 25, 2013·3 cites·29 claims
- 0873US8337733B2Preparation of compositions with essentially noncrystalline embedded macrolide antibioticsWESTEDT ULRICH·Filed 2008·Granted Dec 25, 2012·6 cites·19 claims
- 0973US7846477B2Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrierABBOTT GMBH & CO KG·Filed 2003·Granted Dec 7, 2010·7 cites·22 claims
- 1073US7393840B2Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation baseBASF AG·Filed 2001·Granted Jul 1, 2008·8 cites·21 claims
- 1171US6669883B1Method and device for producing different solid dosage formsABBOTT LAB·Filed 2000·Granted Dec 30, 2003·24 cites·7 claims
- 1270US6669879B1Method for producing solid dosing formsABBOTT LAB·Filed 1999·Granted Dec 30, 2003·34 cites·9 claims
- 1365US9078921B2Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing sameRosenberg Jörg·Filed 2007·Granted Jul 14, 2015·1 cites·20 claims
- 1464US2021353555A1Nanoparticles based on optionally alkoxylated poly(alkyl cyanoacrylates) having a defined degree of polymerizationABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 1562US2012225953A1Self-Emulsifying Active Ingredient Formulation and the Use of this FormulationBERNDL GUNTHER·Filed 2012·Application pending·0 cites
- 1662US2013004578A1Solid Pharmaceutical Dosage FormulationABBVIE INC·Filed 2012·Application pending·0 cites
- 1761US6488939B1Cleavable solid dosage forms and method for the production thereofABBOTT LAB·Filed 1999·Granted Dec 3, 2002·50 cites·10 claims
- 1859US2009302493A1Process for producing a solid dispersion of an active ingredientABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 1959US2009311414A1Process for producing a solid dispersion of an active ingredientABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 2059US2011123652A1Self-emulsifying active substance formulation and use of this formulationBERNDL GUNTHER·Filed 2010·Application pending·0 cites
- 2157US2018185287A1Formulation Obtained from a Powder Mixture Comprising an Inorganic PigmentABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2257US2010297223A1Pharmaceutical dosage form comprising a liquid or flowable core compositionABBOTT GMBH & CO KG·Filed 2008·Application pending·0 cites
- 2357US2008107733A1Formulation Obtained From A Powder Mixture Comprising An Inorganic PigmentFASTNACHT KATJA·Filed 2005·Application pending·0 cites
- 2455US2009274731A1Production of enveloped pharmaceutical dosage formsABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 2553US2009220596A1Composition and Dosage Form Comprising a Solid or Semi-Solid MatrixABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 2652US10653625B2Production of dosage forms comprising a solid dispersion of a microcrystalline agentROSENBERG JOERG·Filed 2006·Granted May 19, 2020·0 cites·13 claims
- 2752US2007190142A1Dosage forms for the delivery of drugs of abuse and related methodsABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 2847US9616130B2Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing sameABBVIE DEUTSCHLAND·Filed 2015·Granted Apr 11, 2017·0 cites·20 claims
- 2946US2018325833A1Nanoparticles based on optionally alkoxylated poly(alkyl cyanoacrylates) having a defined degree of polymerizationABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3046US2010143459A1Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitorABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 3145US6737005B1Method of producing solid dosage formsABBOTT GMBH & CO KG·Filed 1999·Granted May 18, 2004·25 cites·7 claims
- 3244US2006269610A1Method for producing water dispersible dry powders from poorly soluble compoundsROSENBERG JOERG·Filed 2003·Application pending·0 cites
- 3343US2002151578A1Formulation based on lipoic acid, process for its production and the use of this formulation for oral administration of lipoic acidFiled 2002·Application pending·0 cites
- 3441US2009050262A1Production of Dosing Molds from Active Substance-Containing MeltsROSENBERG JORG·Filed 2006·Application pending·0 cites
- 3540US9028876B2Rate-controlled particlesHANTKE THOMAS·Filed 2012·Granted May 12, 2015·0 cites·16 claims
- 3639US8673344B2Solid dosage form with a film containing an active substance, as well as its method of productionROSENBERG JOERG·Filed 2007·Granted Mar 18, 2014·0 cites·20 claims
- 3738US2003153608A1Torasemide-containing pharmaceutical preparationsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →